CN101519379A - Method for preparing 5-methylprazine-2-carboxylic acid - Google Patents

Method for preparing 5-methylprazine-2-carboxylic acid Download PDF

Info

Publication number
CN101519379A
CN101519379A CN200910068469A CN200910068469A CN101519379A CN 101519379 A CN101519379 A CN 101519379A CN 200910068469 A CN200910068469 A CN 200910068469A CN 200910068469 A CN200910068469 A CN 200910068469A CN 101519379 A CN101519379 A CN 101519379A
Authority
CN
China
Prior art keywords
preparation
gram
carboxylic acid
consumption
saturated aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN200910068469A
Other languages
Chinese (zh)
Other versions
CN101519379B (en
Inventor
洪浩
陈迥
陈朝勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liaoning kailaiying Medical Chemical Co. Ltd.
Original Assignee
Asymchem Laboratories Fuxin Co Ltd
Asymchem Laboratories Tianjin Co Ltd
Asymchem Laboratories Jilin Co Ltd
Asymchem Life Science Tianjin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asymchem Laboratories Fuxin Co Ltd, Asymchem Laboratories Tianjin Co Ltd, Asymchem Laboratories Jilin Co Ltd, Asymchem Life Science Tianjin Co Ltd filed Critical Asymchem Laboratories Fuxin Co Ltd
Priority to CN2009100684698A priority Critical patent/CN101519379B/en
Publication of CN101519379A publication Critical patent/CN101519379A/en
Application granted granted Critical
Publication of CN101519379B publication Critical patent/CN101519379B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides a method for preparing 5-methylprazine-2-carboxylic acid. The preparation method comprises the steps: using 5-methyl-2and3- pyrazine 2-carboxylic acid as raw material, carrying out photophobism reaction in a saturated saline solution, and obtaining 5-methylprazine-2-carboxylic acid as a final product. The preparation method optimizes the process from the source on the basis of the principle of water decarboxylation, thereby being a method for effective decarboxylation in a saline solution at lower temperature. Moreover, in the preparation method, no organic solvent is added in the chemical reaction, no pollution is generated, the condition is mild, the reaction in the whole technological process has no high temperature, high selectivity and few by-products, thus the preparation method is a simple and available pollution-free method which has the capability of large-scale production.

Description

The preparation method of a kind of 5-methylpyrazine-2-carboxylic acid
(1) technical field:
The present invention relates to the preparation method of a kind of 5-methylpyrazine-2-carboxylic acid.
(2) background technology:
Decarboxylic reaction generally is to utilize the unstable of compound to heat, and by the vacuum decarboxylation, methods such as solvent decarboxylation and the decarboxylation of water medium mesohigh are finished.
The vacuum decompression decarboxylation is to utilize vacuum to take out the carbonic acid gas that generates after the dereaction, thereby reaction is carried out to positive dirction.This method need add joins specific apparatus, and the early stage input of producing is bigger.
The solvent decarboxylation is to select higher solvent of boiling point such as dimethylbenzene for use, and trimethylbenzene carries out decarboxylation about 140~180 ℃.The shortcoming of this kind method is that cost is higher, need expend a large amount of organic solvents, and by product is more and be difficult to remove, and carbonization phenomenon is comparatively serious because temperature of reaction is very high.
Decarboxylation in the water report among the patent EP0194671 that pH need be strict controlled in 0.7~2.2 in the decarboxylation procedure, and temperature of reaction is 155~170 ℃ because its green characteristics have more research in recent years.Reporting too among the CN96100260 needs strict control pH 3.5~8, and temperature of reaction is 100~160 ℃ reacts down, and this method can be in decompression, and normal pressure adds to depress and carries out.This kind method condition harshness, though be but that the water react temperature is higher, be unfavorable for large-scale production.
(3) summary of the invention:
Technical problem to be solved by this invention is to provide the preparation method of a kind of 5-methylpyrazine-2-carboxylic acid.
For solving the problems of the technologies described above, technical scheme of the present invention is:
The preparation method of a kind of 5-methylpyrazine-2-carboxylic acid, with 5-methyl-2,3-pyrazine dioctyl phthalate is raw material lucifuge reaction in saturated aqueous common salt, obtains finished product 5-methylpyrazine-2-carboxylic acid, concrete preparation process is as follows:
(1) with the saturated aqueous common salt is solvent, adds main raw material 5-methyl-2,3-pyrazine dioctyl phthalate
Figure A200910068469D00041
Add a little salt again and make the salt solution supersaturation, heat temperature raising is to 105-115 ℃, and back flow reaction 8-15 hour to main raw material 5-methyl-2,3-pyrazine dioctyl phthalate
Figure A200910068469D00042
Disappear; Wherein the consumption of saturated aqueous common salt is at every gram
Figure A200910068469D00043
5ml-10ml;
(2) question response is finished, and reduces to room temperature, suction filtration, and filtrate extracts with butanone, and organic phase merges the back and concentrates, and cooling crystallization in ice-water bath, suction filtration promptly get product; Wherein butanone consumption at every gram 15-25ml.
The preparation method of above-mentioned a kind of 5-methylpyrazine-2-carboxylic acid, wherein the consumption of step (1) saturated aqueous common salt is at every gram
Figure A200910068469D00045
5ml~8ml; Step (2) butanone consumption at every gram
Figure A200910068469D00046
15~18mL.
The preparation method of above-mentioned a kind of 5-methylpyrazine-2-carboxylic acid, wherein the consumption of step (1) saturated aqueous common salt is at every gram
Figure A200910068469D00047
8ml; Step (2) butanone consumption at every gram
Figure A200910068469D00048
18mL.
Superiority of the present invention:
1, preparation method of the present invention is based on the principle of decarboxylation in the water, from the source, technology is optimized, be under a kind of lesser temps in salt solution the effective method of decarboxylation, by in supersaturated brine in 110 ℃ of decarboxylations, obtain end product 5-methylpyrazine-2-carboxylic acid through aftertreatment again, purity can reach 98%; 2, aforesaid method chemical reaction organic solvent-free; the environmental protection mild condition; reaction in the whole technological process, no pyroreaction, and ripe on this Technology; because selectivity height; so isomer impurities can be controlled at 0.5%~3%, cost is low, and by product is few; be the method for simple environmental protection, possess the ability of large-scale production.
(4) description of drawings:
Fig. 1: synthetic Chemical reaction process.
(5) embodiment:
Embodiment 1:
In the 2L four-hole bottle, add 80g 5-methyl-2,3-pyrazine dioctyl phthalate
Figure A200910068469D00052
(1eq), be warmed up to 110oC back flow reaction 10h with 0.96kg saturated aqueous common salt (10ml/g).When question response proceeds to HPLC demonstration transformation efficiency 91%, reduce to room temperature, suction filtration, filtrate merges the back and concentrates with 1.6kg butanone (25mL/g), organic phase, and cooling crystallization in ice-water bath, suction filtration promptly get product 33.5g.HPLC purity: 98%, isomer impurities content: 1.1%, productive rate: 55%.
Embodiment 2:
In the 2L four-hole bottle, add 36g 5-methyl-2,3-pyrazine dioctyl phthalate
Figure A200910068469D00053
(1eq), be warmed up to 108oC back flow reaction 8h with 349g saturated aqueous common salt (8ml/g).When question response proceeds to HPLC demonstration transformation efficiency 92%, reduce to room temperature, suction filtration, filtrate merges the back and concentrates with 524g butanone (18mL/g), organic phase, and cooling crystallization in ice-water bath, suction filtration promptly get product 15.3g.HPLC purity: 98%, isomer impurities content: 0.7%, productive rate: 56.2%.
Embodiment 3:
In the 2L four-hole bottle, add 54g 5-methyl-2,3-pyrazine dioctyl phthalate
Figure A200910068469D00061
(1eq), be warmed up to 105oC back flow reaction 8h with 327g saturated aqueous common salt (5ml/g).When question response proceeds to HPLC demonstration transformation efficiency 90%, reduce to room temperature, suction filtration, filtrate merges the back and concentrates with 655g butanone (15mL/g), organic phase, and cooling crystallization in ice-water bath, suction filtration promptly get product 22.5g.HPLC purity: 98%, isomer impurities content: 2.0%, productive rate: 55%.
Embodiment 4:
In the 2L four-hole bottle, add 100g 5-methyl-2,3-pyrazine dioctyl phthalate
Figure A200910068469D00062
(1eq), be warmed up to 115 ℃ of back flow reaction 15h with 1.2kg saturated aqueous common salt (10ml/g).When question response proceeds to HPLC demonstration transformation efficiency 94%, reduce to room temperature, suction filtration, filtrate merges the back and concentrates with 2.0kg butanone (25mL/g), organic phase, and cooling crystallization in ice-water bath, suction filtration promptly get product 40.2g.HPLC purity: 98%, isomer impurities content: 1.6%, productive rate: 53%.

Claims (3)

1, the preparation method of a kind of 5-methylpyrazine-2-carboxylic acid is characterized in that concrete preparation process is as follows:
(1) with the saturated aqueous common salt is solvent, adds main raw material 5-methyl-2,3-pyrazine dioctyl phthalate Add a little salt again and make the salt solution supersaturation, heat temperature raising is to 105-115 ℃, and back flow reaction 8-15 hour to main raw material 5-methyl-2,3-pyrazine dioctyl phthalate
Figure A200910068469C00022
Disappear; Wherein the consumption of saturated aqueous common salt is at every gram
Figure A200910068469C00023
5ml-10ml;
(2) question response is finished, and reduces to room temperature, suction filtration, and filtrate extracts with butanone, and organic phase merges the back and concentrates, and cooling crystallization in ice-water bath, suction filtration promptly get product; Wherein butanone consumption at every gram
Figure A200910068469C00024
15-25ml.
2, according to the preparation method of the described a kind of 5-methylpyrazine of claim 1-2-carboxylic acid, the consumption that it is characterized in that step (1) saturated aqueous common salt wherein is at every gram
Figure A200910068469C00025
5ml~8ml; Step (2) butanone consumption at every gram
Figure A200910068469C00026
15~18mL.
3, according to the preparation method of claim 1 or 2 described a kind of 5-methylpyrazine-2-carboxylic acids, the consumption that it is characterized in that step (1) saturated aqueous common salt wherein is at every gram 8ml; Step (2) butanone consumption at every gram
Figure A200910068469C00028
18mL.
CN2009100684698A 2009-04-14 2009-04-14 Method for preparing 5-methylprazine-2-carboxylic acid Active CN101519379B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100684698A CN101519379B (en) 2009-04-14 2009-04-14 Method for preparing 5-methylprazine-2-carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100684698A CN101519379B (en) 2009-04-14 2009-04-14 Method for preparing 5-methylprazine-2-carboxylic acid

Publications (2)

Publication Number Publication Date
CN101519379A true CN101519379A (en) 2009-09-02
CN101519379B CN101519379B (en) 2011-02-02

Family

ID=41080202

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100684698A Active CN101519379B (en) 2009-04-14 2009-04-14 Method for preparing 5-methylprazine-2-carboxylic acid

Country Status (1)

Country Link
CN (1) CN101519379B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103664805A (en) * 2013-12-05 2014-03-26 华北水利水电大学 Method for preparing acipimox
CN105418342A (en) * 2015-11-09 2016-03-23 贝利化学(张家港)有限公司 High-temperature decarboxylation method
CN108059621A (en) * 2018-01-26 2018-05-22 常州工程职业技术学院 A kind of process for purification of high-purity 5-Methylpyrazine-2-carboxylic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769492A (en) * 1985-03-13 1988-09-06 Nippon Shokubai Kagaku Kogyo Co., Ltd. Method for production of 2,3,4,5-tetrafluorobenzoic acid
CN1155581C (en) * 2002-07-17 2004-06-30 常州市康瑞化工有限公司 Process for preparing 5-methyl pyrazine-2-carboxylic acid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103664805A (en) * 2013-12-05 2014-03-26 华北水利水电大学 Method for preparing acipimox
CN103664805B (en) * 2013-12-05 2016-05-11 华北水利水电大学 A kind of method of preparing Acipimox
CN105418342A (en) * 2015-11-09 2016-03-23 贝利化学(张家港)有限公司 High-temperature decarboxylation method
CN108059621A (en) * 2018-01-26 2018-05-22 常州工程职业技术学院 A kind of process for purification of high-purity 5-Methylpyrazine-2-carboxylic acid

Also Published As

Publication number Publication date
CN101519379B (en) 2011-02-02

Similar Documents

Publication Publication Date Title
CN102040606B (en) Synthetic method of vinpocetine
CN101519379B (en) Method for preparing 5-methylprazine-2-carboxylic acid
CN104478746B (en) A kind of preparation method of DL-Lys
CN102603760A (en) Synthesis method of anti-angina drug isosorbide mononitrate
CN104530090A (en) Pyridine derivative preparing method
CN102731340B (en) Preparation method of demethyl aureomycin hydrochloride
CN104086475B (en) A kind of preparation method of N-benzyloxycarbonyl group-L-prolineamide
CN101704724B (en) Novel method for preparing high-proportion trans, trans-4-(4'-alkyl cyclohexyl) cyclohexyl alcohol liquid crystal intermediate compound
CN103467350B (en) (S) preparation method of-AzeOH
CN109134204B (en) Synthesis method of intermediate 2-bromo-4-fluoro-5-chlorophenol
KR20170036231A (en) Purifying method of dodecanedioic acid
CN104628625A (en) Synthesis method of N-boc-4-hydroxypiperidine
CN103601669B (en) A kind of synthetic method of 1-tertbutyloxycarbonyl-2-methyl-4-piperidones
CN103224489B (en) Method for enhancing production yield and rate of esomeprazole
CN105646306B (en) Preparation method of 4-methylthio phenylacetic acid
CN103145692A (en) Preparation method of 4, 5-dihydro-6H-cyclopenta[b]thiophene-6-ketone
CN105439892A (en) Refining method for lisinopril hydride
CN111377893B (en) Synthesis method of 3-n-butyl-l (3H) -isobenzofuranone
CN103030591B (en) Adsorption purification method of 2, 3, 5-trimethyl pyridine
CN102976993A (en) Synthetic method of 3-hydroxyazetidine hydrochloride
CN104447798A (en) Method for synthesizing cefmenoxime hydrochloride
CN104109063B (en) The preparation method of divinyl anthracene compounds
CN115611829A (en) Preparation method of (S) -3-hydroxytetrahydrofuran
CN105646262A (en) Flutamide synthesis process
CN108929245A (en) The preparation method of escitalopram process impurity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 300457 No. seventh, 71 Avenue, Tianjin economic and Technological Development Zone

Co-patentee after: Asymchem Medical Group (Tianjin) Inc.

Patentee after: Asymchem Life Science and Tecnology (Tianjin) Co., Ltd.

Co-patentee after: Asymchem Medical Chemical (Fuxin) Technology Co., Ltd.

Co-patentee after: Jilin Asymchem Medicinal and Pharmaceutical Chemistry Co., Ltd.

Address before: 300457 No. seventh, 71 Avenue, Tianjin economic and Technological Development Zone

Co-patentee before: Kailaiying Medical Chemical (Tianjin) Co., Ltd.

Patentee before: Asymchem Life Science and Tecnology (Tianjin) Co., Ltd.

Co-patentee before: Asymchem Medical Chemical (Fuxin) Technology Co., Ltd.

Co-patentee before: Jilin Asymchem Medicinal and Pharmaceutical Chemistry Co., Ltd.

TR01 Transfer of patent right

Effective date of registration: 20180704

Address after: 123129 Yi Mo Tu village (fluorinated Industrial Park), Yi Tu Town, Fumeng County, Fuxin, Liaoning

Patentee after: Liaoning kailaiying Medical Chemical Co. Ltd.

Address before: 300457 No. 71 Seventh Avenue, Tianjin economic and Technological Development Zone

Co-patentee before: Asymchem Medical Group (Tianjin) Inc.

Patentee before: Asymchem Life Science and Tecnology (Tianjin) Co., Ltd.

Co-patentee before: Asymchem Medical Chemical (Fuxin) Technology Co., Ltd.

Co-patentee before: Jilin Asymchem Medicinal and Pharmaceutical Chemistry Co., Ltd.

TR01 Transfer of patent right